期刊文献+

水飞蓟宾-磷脂酰胆碱复合物对氯仿所致肝损伤的保护作用 被引量:1

Protective Effect of Silybin-phosphatidylcholine Compound on Acute Liver Injury Induced by CHCl_3 in Mice
下载PDF
导出
摘要 目的研究水飞蓟宾-磷脂酰胆碱复合物(SPC)对氯仿(CHCl3)所致小鼠肝损伤的保护作用。方法40只小鼠随机分成4组:正常对照组、CHCl3损伤组、CHCl3+SPC低剂量组、CHCl3+SPC高剂量组。前两组给予羧甲基纤维素钠(CMC-Na)混悬液灌胃,后两组分别给予SPC,连续8 d。最后一天给予SPC后2 h腹腔注射CHCl3致肝损伤,16 h后采血、分离血清,检测血清中ALT、AST活力,测肝组织中MDA和SOD值。结果损伤组小鼠血清中ALT、AST和肝组织中MDA值明显升高,SPC明显降低血清中ALT、AST值,SPC组肝组织中MDA值降低、SOD活力增加,SPC组与损伤组比较,差异有统计学意义(P<0.05)。结论SPC对CHCl3造成的急性肝损伤有明显的保护作用。 Objective To investigate the protective effect of silybin-phosphatidyleholine compound(SPC) on acute liver injury induced by CHCI3 in mice. Methods Forty mice were randomly and equally divided into four groups: normal group, liver injury group, SPC Ⅰ group and SPC Ⅱ group. Intragastric administration of 0.50/oo CMC-Na(sodium carboxymethycellulose)suspension were given to the normal and liver injury groups, and two dosages of SPC suspension(150 mg/kg and 300 mg/kg)were respectively given to SPC Ⅰ and SPC Ⅱ groups successively for eight days. Two hours after last administration of SPC, liver injury of animals was induced with 500 mg/kg of CHCI3. 16 h later, the levels of serum ALT, AST activity, and MDA and SOD in liver were detected by biochemical method. Results Administration of SPC greatly attenuated the lesion development by CHCl3, accompanied by great decrease in serum ALT, AST activity, lower hepatic content of MDA and increase activity of SOD(P〈0.05). Conclusions SPC shows significant protective effect on CHCl3-induced hepatic injury in mice.
机构地区 新乡医学院
出处 《工业卫生与职业病》 CAS CSCD 北大核心 2008年第6期342-344,共3页 Industrial Health and Occupational Diseases
基金 河南省科技攻关项目(001180203)
关键词 水飞蓟宾-磷脂酰胆碱复合物 氯仿 肝损伤 保护作用 Silybin-phosphatidylcholine compound ( SPC ) Chloroform ( CHCl3 ) Liver injury Protective effect
  • 相关文献

参考文献6

二级参考文献20

  • 1陈大为,刘立民,丁玉芝,李三鸣,刘茜英.水飞蓟素(益肝灵)片剂溶出速率的研究 Ⅱ.水飞蓟素亲水辅料研磨混合物制备及溶出的研究[J].中成药,1993,15(5):2-4. 被引量:13
  • 2林炳杰.一起隐匿式三氯甲烷职业中毒事故调查报告[J].中国职业医学,2000,7(4):33-33.
  • 3Flora K, Hahn M, Rose H, et al. Milk thistle (silybum marianum)for the therapy of liver disease[J]. Am J Gastroenterol, 1998,93(2): 139 - 143.
  • 4Luper S. A review of plants used in the treatment of liver disease:part 1[J]. Altern Med Rev, 1998,3(6) :410 - 412.
  • 5FloraK,HahnM,RoseH,etal.Milkthistle(Silybummarianum)forthetherapyofliverdisease[J].AmJGastroenterol,1998,93(2):139.
  • 6LuperS.Areviewofplantsusedinthetreatmentofliverdisease:part1[J].AltemMedRev,1998,3(6):410.
  • 7SkottovaN,KrecrnanV.Silymarinasapotentialhypocholesterolaemicdrug[J].PhysiolRes,1988,47(1):1.
  • 8deGrootH,RauenU.Tissueinjurybyreactiveoxygenspeciesandtheprotectiveeffectsofflavonoids[J].FundamClinPharmacol,1998,12(3):249.
  • 9BindoliA.Inhibitoryactionofsilymarinoflipidperoxideformationinratlivermitochondriaandmicrosomes[J].BiochemPharmacol,1977,26:2405.
  • 10KonyaL,KekesiV,NagyST,etal.Effectofantioxidanttreatmentonthemyocardiumduringreperfusionindogs[J].ActaPhysiolHung,1993,81(3):219.

共引文献41

同被引文献5

  • 1Spirli C, Nathanson MH, Fiorotto R, et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium[J]. Gastroenterology, 2001, 121(1): 156-169.
  • 2Boigk G, Stroedterl, Herbsr H, et aI. Silymarin retards collagen accumulation in early and advanced billiary fibrosis secondary to complete bile duct obliteration in rats[J]. Hepatology, 1997, 26(3): 643-649.
  • 3Kuloglu Z, Kansu A, Demirceken F, et al. The influence of interferon-alpha and combination interferon-alpha and lamivudine therpy on height and weight in children with chronic hepatitis B infection[J]. Pediatr Endocrinol Metab, 2007, 20(5): 615-620.
  • 4刘本付,唐明新,范毕成,汪隆海.α-干扰素、拉米夫定治疗慢性乙型肝炎临床观察[J].中华全科医学,2008,6(9):936-937. 被引量:11
  • 5中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部